SUROVA
Unknown
5,000 enrolled
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
Unknown
250 enrolled
A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
Phase 2 Unknown
29 enrolled
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Unknown
120 enrolled
Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
Phase 3 Unknown
420 enrolled
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC
Unknown
150 enrolled
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
Phase 2 Unknown
150 enrolled
Total Neoadjuvant Therapy in Rectal Cancer Treatment
Phase 4 Unknown
280 enrolled
Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study
Unknown
400 enrolled
LUNG ART
Phase 3 Unknown
500 enrolled
Lymphadenectomy in NSCLC With and Without Adjuvant Therapy
Unknown
250 enrolled
The Clinical Study of Adjuvant Chemotherapy on Intestinal and Urethral Flora in Patients With Gastric and Colon Cancer
Phase NA Unknown
120 enrolled
EHTASEOCCS
Phase 3 Unknown
310 enrolled
Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy
Phase 2 Unknown
99 enrolled
REALIZATION
Phase 2 Unknown
102 enrolled
EPHOS-B
Phase 3 Unknown
257 enrolled
TACT2
Phase 3 Unknown
4,400 enrolled
TNTCRT
Phase 3 Unknown
458 enrolled
EHNPCTASEOC
Phase 3 Unknown
263 enrolled
ST03
Phase 2/3 Unknown
1,103 enrolled
HIPEC
Phase 3 Unknown
640 enrolled
Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection
Phase 3 Unknown
290 enrolled
Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer
Phase 2 Unknown
230 enrolled
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Phase 3 Unknown
486 enrolled
Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer
Phase 3 Unknown
598 enrolled
A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Phase NA Unknown
20 enrolled
A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.
Phase 3 Unknown
588 enrolled
Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer
Phase NA Unknown
464 enrolled
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
Phase 3 Unknown
1,258 enrolled
Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy
Phase 3 Unknown
550 enrolled
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Phase 3 Unknown
350 enrolled
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Phase 3 Unknown
316 enrolled
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
Phase 2 Unknown
57 enrolled
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Phase 2 Unknown
50 enrolled
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Phase 2 Unknown
200 enrolled
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Phase 2 Unknown
80 enrolled
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Phase 2 Unknown
20 enrolled
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
Phase NA Unknown
75 enrolled
Tamoxifen in Treating Women With Breast Cancer
Phase 3 Unknown
20,000 enrolled
Lymphocyte Therapy in Treating Patients With Kidney Cancer
Phase 2 Unknown
90 enrolled
Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer
Phase 3 Unknown
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
Phase 2 Unknown
Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed
Phase 3 Unknown
750 enrolled
Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
Phase 3 Unknown
300 enrolled
S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
Phase 2 Unknown
50 enrolled
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer
Phase 2 Unknown
70 enrolled
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
Phase 3 Unknown
105 enrolled
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
Phase 2 Unknown
29 enrolled
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
Phase 2 Unknown
47 enrolled
High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma
Phase 2 Unknown
29 enrolled